A Study of AL102 in Patients With Progressing Desmoid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of AL102 in Patients With Progressing Desmoid Tumors	Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, connective tissue neoplasm, desmoid tumor, fibroma, neoplasm	Active, not recruiting	Phase 2 / Phase 3	2026-06-08		NCT04871282

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Immunome, Inc.	5

53 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Addenbrooke's Hospital	Cambridge	United Kingdom	40
Adelaide Cancer Centre	Kurralta Park	Australia	1
ASAN Medical Center	Seoul	South Korea	1
Campus Bio-Medico University Hospital	Rome	Italy	1
Catalan Institute of Oncology (ICO)	Barcelona	Spain	2
Chris O'Brien Lifehouse	Camperdown	Australia	46
City of Hope	Duarte	United States	238
Cleveland Clinic	Cleveland	United States	558
Columbia University Irving Medical Center	New York	United States	234
Erasmus Medisch Centrum	Rotterdam	Netherlands	2
Fox Chase Cancer Center	Philadelphia	United States	259
Fred Hutchinson Cancer Center	Seattle	United States	250
Hadassah University Hospital - Ein Kerem	Jerusalem	Israel	7
Helios Klinikum Berlin-Buch	Berlin	Germany	34
Hospital Universitario 12 de Octubre	Madrid	Spain	359
Hospital Universitario Fundacion Jimenez Diaz	Madrid	Spain	63
Hospital Universitario Miguel Servet	Zaragoza	Spain	92
Irccs Fondazione Istituto Nazionale Dei Tumori	Milan	Italy	3
IRCCS Istituto Ortopedico Rizzoli	Bologna	Italy	26
Jefferson City Medical Group	Jefferson City	United States	7
Jefferson University Hospital	Philadelphia	United States	3
Leiden University Medical Center	Leiden	Netherlands	54
Levine Cancer Institute	Charlotte	United States	110
Mannheim university medical center	Mannheim	Germany	1
Maria Sklodowska-Curie National Research Institute of Oncology	Warsaw	Poland	2

Clinical trials